NASDAQ:DOCS

Doximity (DOCS) Stock Forecast, Price & News

$20.16

+0.27 (+1.36%)

(As of 09/25/2023 ET)

Compare

Today's Range: $19.71
▼
$20.38
50-Day Range: $19.89
▼
$35.83
52-Week Range: $19.71
▼
$40.12

Volume: 3.11 million shs
Average Volume: 1.96 million shs
Market Capitalization: $3.93 billion

P/E Ratio: 36.66
Dividend Yield: N/A
Price Target: $29.50

Doximity MarketRank™ Forecast

Analyst Rating: Hold
2.00 Rating Score
Upside/Downside: 46.3% Upside
$29.50 Price Target
Short Interest: N/A
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 0.14
Based on 3 Articles This Week
Insider Trading: Selling Shares
$786,781 Sold Last Quarter
Proj. Earnings Growth: 18.33%
From $0.60 to $0.71 Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.92 out of 5 stars

Medical Sector

53rd out of 961 stocks

Custom Computer Programming Services Industry

2nd out of 24 stocks

4.0

Analyst's Opinion

Consensus Rating
Doximity has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on 2 buy ratings, 6 hold ratings, and 2 sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $29.50, Doximity has a forecasted upside of 46.3% from its current price of $20.16.
Amount of Analyst Coverage
Doximity has been the subject of 8 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

N/A

Short Interest

Short Interest
There is no current short interest data available for DOCS.

0.0

Dividend Strength

Dividend Yield
Doximity does not currently pay a dividend.
Dividend Growth
Doximity does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for DOCS.

1.7

News and Social Media Coverage

News Sentiment
Doximity has a news sentiment score of 0.14. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.51 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 3 news articles for Doximity this week, compared to 3 articles on an average week.
Search Interest
Only 14 people have searched for DOCS on MarketBeat in the last 30 days. This is a decrease of -30% compared to the previous 30 days.
MarketBeat Follows
5 people have added Doximity to their MarketBeat watchlist in the last 30 days. This is an increase of 25% compared to the previous 30 days.

3.3

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Doximity insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $786,781.00 in company stock.
Percentage Held by Insiders
39.40% of the stock of Doximity is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
54.65% of the stock of Doximity is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

3.1

Earnings and Valuation

Earnings Growth
Earnings for Doximity are expected to grow by 18.33% in the coming year, from $0.60 to $0.71 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Doximity is 36.66, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 122.24.
Price to Earnings Ratio vs. Sector
The P/E ratio of Doximity is 36.66, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 140.37.
Price to Earnings Growth Ratio
Doximity has a PEG Ratio of 3.22. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
Doximity has a P/B Ratio of 4.05. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Doximity (NASDAQ:DOCS) Stock

Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers. It primarily serves pharmaceutical manufacturers and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.

DOCS Price History

30 days | 90 days | 365 days | Advanced Chart

DOCS Stock News Headlines

September 19, 2023 | americanbankingnews.com

Reviewing Amdocs (NASDAQ:DOX) & Doximity (NASDAQ:DOCS)

September 6, 2023 | finance.yahoo.com

Implied Volatility Surging for Doximity (DOCS) Stock Options

September 25, 2023 | Behind the Markets (Ad)

The single greatest medical breakthrough of all time?

We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.

September 6, 2023 | markets.businessinsider.com

Morgan Stanley Keeps Their Sell Rating on Doximity (DOCS)

September 5, 2023 | markets.businessinsider.com

Where Doximity Stands With Analysts

August 26, 2023 | prnewswire.com

Doximity, Inc. Investigation Notice: Kessler Topaz Meltzer & Check, LLP is Investigating Securities Fraud Claims on Behalf of Doximity, Inc. (NYSE: DOCS) Investors

August 24, 2023 | msn.com

Doximity: Rating Downgrade As Investors Shift Focus To The Near-Term Outlook

August 23, 2023 | benzinga.com

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Doximity, Inc. Investors to Inquire About Securities Class Action Investigation – DOCS

September 25, 2023 | Legacy Research (Ad)

Watch SHOCKING Footage of AI Facility with Ties to Elon Musk

I recently traveled more than 3,000 miles and shot this video outside what could end up being Elon Musk’s biggest secret. Most people don’t know about this facility, but it could be the most important AI project in the world. What’s happening inside these walls is so important that our government has declared it a matter of national security.

August 18, 2023 | benzinga.com

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Doximity, Inc. - DOCS

August 16, 2023 | finance.yahoo.com

1 Growth Stock Down Nearly 40% to Buy and Hold For 10 Years

August 11, 2023 | markets.businessinsider.com

Robert W. Baird Reaffirms Their Buy Rating on Doximity (DOCS)

August 11, 2023 | msn.com

Wells Fargo Maintains Doximity Inc - (DOCS) Equal-Weight Recommendation

August 11, 2023 | seekingalpha.com

Doximity, Inc. 2024 Q1 - Results - Earnings Call Presentation

August 11, 2023 | msn.com

Doximity Stock Plunges After Cut to Forecast. Analysts Are Concerned.

August 10, 2023 | msn.com

Raymond James Maintains Doximity Inc - (DOCS) Outperform Recommendation

August 9, 2023 | benzinga.com

DOCS Shareholder News: Johnson Fistel Encourages Doximity Shareholders with Losses to Contact the Firm Regarding Investigation

August 9, 2023 | benzinga.com

Why Doximity Stock Took A Nosedive Today

August 9, 2023 | msn.com

Why Shares of Doximity Are Falling Wednesday

August 9, 2023 | markets.businessinsider.com

Pre-market Movers: TYGO, BRSH, TNGX, VERI, DOCS…

August 9, 2023 | investing.com

Doximity tumbles 28% after cutting full-year forecast; earns 2 downgrades

August 9, 2023 | markets.businessinsider.com

Bank of America Securities Sticks to Its Sell Rating for Doximity (DOCS)

August 9, 2023 | msn.com

Doximity (NYSE: DOCS) Crashes after Lowered Guidance

August 9, 2023 | investorplace.com

Why Is Doximity (DOCS) Stock Down 23% Today?

August 9, 2023 | seekingalpha.com

Doximity Earnings: Too Many Problems, Sell

August 8, 2023 | theglobeandmail.com

Doximity (DOCS) Reports Q1: Everything You Need To Know Ahead Of Earnings

August 8, 2023 | finance.yahoo.com

Doximity (DOCS) Surpasses Q1 Earnings and Revenue Estimates

See More Headlines

Receive DOCS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Doximity and its competitors with MarketBeat's FREE daily newsletter.

DOCS Company Calendar

Last Earnings: 8/08/2023
Today: 9/25/2023
Next Earnings (Estimated): 11/09/2023
Fiscal Year End: 3/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Custom computer programming services
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:DOCS
CUSIP: N/A
CIK: 1516513
Web: www.doximity.com
Phone: 650-549-4330
Fax: N/A
Employees: 900
Year Founded: N/A

Price Target and Rating

Average Stock Price Forecast: $29.50
High Stock Price Forecast: $45.00
Low Stock Price Forecast: $21.00
Forecasted Upside/Downside: +45.2%
Consensus Rating: Hold
Rating Score (0-4): 2.00
Research Coverage: 10 Analysts

Profitability

EPS (Most Recent Fiscal Year): $0.55
Trailing P/E Ratio: 36.93
Forward P/E Ratio: 33.85
P/E Growth: 3.22
Net Income: $112.82 million
Net Margins: 27.20%
Pretax Margin: 33.23%
Return on Equity: 13.11%
Return on Assets: 11.25%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 7.46
Quick Ratio: 7.46

Sales & Book Value

Annual Sales: $419.05 million
Price / Sales: 9.44
Cash Flow: $0.73 per share
Price / Cash Flow: 27.69
Book Value: $4.98 per share
Price / Book: 4.08

Miscellaneous

Outstanding Shares: 194,710,000
Free Float: 117,995,000
Market Cap: $3.95 billion
Optionable: Not Optionable
Beta: 1.02

7 Energy Stocks to Buy and Hold Forever

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Key Executives

Mr. Jeffrey A. Tangney (Age 50)
Co-Founder, CEO & Chairperson
Comp: $243.73k

Dr. Nate Gross M.D. (Age 39)
Co-Founder & Chief Strategy Officer
Comp: $455.54k

Ms. Anna Bryson (Age 33)
Chief Financial Officer
Comp: $453.71k

Ms. Jennifer W. Chaloemtiarana (Age 55)
Gen. Counsel & Corp. Sec.
Comp: $504.04k

Mr. Paul Jorgensen (Age 52)
Chief Revenue Officer
Comp: $455.13k

Ms. Shari Buck
Co-founder and SVP People & Ops

Mr. Jey Balachandran
Chief Technology Officer

Mr. Perry Scott Gold
Head of Investor Relations

Jim Rivas
Head of Corp. Communications

Mr. Bruno Miranda
Sr. VP of Engineering

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

DOCS Stock - Frequently Asked Questions

Should I buy or sell Doximity stock right now?: 10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Doximity in the last year. There are currently 2 sell ratings, 6 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" DOCS shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in DOCS, but not buy additional shares or sell existing shares.
View DOCS analyst ratings or view top-rated stocks.
What is Doximity's stock price forecast for 2023?: 10 brokerages have issued twelve-month price targets for Doximity's shares. Their DOCS share price forecasts range from $21.00 to $45.00. On average, they predict the company's share price to reach $29.50 in the next year. This suggests a possible upside of 45.2% from the stock's current price.
View analysts price targets for DOCS or view top-rated stocks among Wall Street analysts.
How have DOCS shares performed in 2023?: Doximity's stock was trading at $33.56 on January 1st, 2023. Since then, DOCS stock has decreased by 39.5% and is now trading at $20.31.
View the best growth stocks for 2023 here.
When is Doximity's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Thursday, November 9th 2023.
View our DOCS earnings forecast.
How were Doximity's earnings last quarter?: Doximity, Inc. (NASDAQ:DOCS) issued its earnings results on Tuesday, August, 8th. The company reported $0.14 earnings per share for the quarter, beating analysts' consensus estimates of $0.11 by $0.03. The firm earned $108.47 million during the quarter, compared to analyst estimates of $106.98 million. Doximity had a trailing twelve-month return on equity of 13.11% and a net margin of 27.20%.
What ETFs hold Doximity's stock?: ETFs with the largest weight of Doximity (NASDAQ:DOCS) stock in their portfolio include Jacob Forward ETF (JFWD), Global X Telemedicine & Digital Health ETF (EDOC), Fidelity Digital Health ETF (FDHT), First Trust Nasdaq Lux Digital Health Solutions ETF (EKG), Janus Henderson Small/Mid Cap Growth Alpha ETF (JSMD), Syntax Stratified MidCap ETF (SMDY), Natixis U.S. Equity Opportunities ETF (EQOP) and BlackRock Future Innovators ETF (BFTR).
What guidance has Doximity issued on next quarter's earnings?: Doximity updated its second quarter 2024 earnings guidance on Tuesday, August, 8th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $108.50 million-$109.50 million, compared to the consensus revenue estimate of $121.35 million.

When did Doximity IPO?: (DOCS) raised $501 million in an IPO on Thursday, June 24th 2021. The company issued 23,300,000 shares at $20.00-$23.00 per share. Morgan Stanley, Goldman Sachs and J.P. Morgan Securities served as the underwriters for the IPO and Piper Sandler, William Blair, Canaccord and Raymond James were co-managers.
What is Doximity's stock symbol?: Doximity trades on the NASDAQ under the ticker symbol "DOCS."
Who are Doximity's major shareholders?: Doximity's stock is owned by many different retail and institutional investors. Top institutional shareholders include BlackRock Inc. (5.49%), Clearbridge Investments LLC (3.45%), Baillie Gifford & Co. (3.39%), Eventide Asset Management LLC (2.00%), State Street Corp (1.63%) and Geode Capital Management LLC (1.08%). Insiders that own company stock include Anna Bryson, Craig Overpeck, Gilbert H Kliman, Interwest Partners X Lp, Joseph B Kleine, Kevin Spain, Kira Scherer Wampler, Paul W Jorgensen and Timothy S Cabral.
View institutional ownership trends.
How do I buy shares of Doximity?: Shares of DOCS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Doximity's stock price today?: One share of DOCS stock can currently be purchased for approximately $20.31.
How much money does Doximity make?: Doximity (NASDAQ:DOCS) has a market capitalization of $3.95 billion and generates $419.05 million in revenue each year. The company earns $112.82 million in net income (profit) each year or $0.55 on an earnings per share basis.
How many employees does Doximity have?: The company employs 900 workers across the globe.
How can I contact Doximity?: The official website for the company is www.doximity.com. The company can be reached via phone at 650-549-4330 or via email at ir@doximity.com.

This page (NASDAQ:DOCS) was last updated on 9/25/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Doximity (DOCS) Stock Forecast, Price & News

Doximity MarketRank™ Forecast

Overall MarketRank™

Analyst's Opinion

Short Interest

Short Interest

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

News Sentiment

News Coverage This Week

Search Interest

MarketBeat Follows

Company Ownership

Earnings and Valuation

About Doximity (NASDAQ:DOCS) Stock

DOCS Price History

DOCS Stock News Headlines

DOCS Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Insiders & Institutions

DOCS Stock - Frequently Asked Questions

Overall MarketRank^™